Spandidos Publications style
Wang M, Jiang R, Liu J, Xu X, Sun G, Zhao D and Sun L: [Corrigendum] 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy <em>in vitro</em>. Mol Med Rep 24: 620, 2021
APA
Wang, M., Jiang, R., Liu, J., Xu, X., Sun, G., Zhao, D., & Sun, L. (2021). [Corrigendum] 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy <em>in vitro</em>. Molecular Medicine Reports, 24, 620. https://doi.org/10.3892/mmr.2021.12259
MLA
Wang, M., Jiang, R., Liu, J., Xu, X., Sun, G., Zhao, D., Sun, L."[Corrigendum] 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy <em>in vitro</em>". Molecular Medicine Reports 24.3 (2021): 620.
Chicago
Wang, M., Jiang, R., Liu, J., Xu, X., Sun, G., Zhao, D., Sun, L."[Corrigendum] 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy <em>in vitro</em>". Molecular Medicine Reports 24, no. 3 (2021): 620. https://doi.org/10.3892/mmr.2021.12259